Revolution Medicines, Inc. (RVMD) stock
RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
$162.69−4.18 (-2.50%)
Close on Nov 17, 2026Market cap $34.87BP/E –Yield –
Revolution Medicines gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Revolution Medicines
Revolution Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?